Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A CRISPR-dCas13 RNA-editing tool to study alternative splicing. | Nucleic Acids Res | 2024 | 39162234 | PubTator, text mining | PubMed |
| Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer. | Curr Med Chem | 2024 | 39129286 | PubTator, text mining | PubMed |
| HCC-1 Accelerates Atherosclerosis by Inducing Endothelial Cell and Macrophage Pyroptosis and Serves as an Early Diagnostic Biomarker. | Arterioscler Thromb Vasc Biol | 2024 | 39087347 | PubTator, text mining | PubMed |
| Genomic profiling of methicillin-sensitive Staphylococcus aureus (MSSA) isolates in Kuwait hospitals. | Front Microbiol | 2024 | 39086653 | PubTator, text mining | PubMed |
| The chemokine CCL14 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. | Discov Oncol | 2024 | 39030403 | PubTator, text mining | PubMed |
| Integrating LiDAR Sensor Data into Microsimulation Model Calibration for Proactive Safety Analysis. | Sensors (Basel) | 2024 | 39001172 | PubTator, text mining | PubMed |
| The impact of clomiphene citrate on the endometrium in comparison to gonadotropins in intrauterine insemination cycles: is it thinner and does it matter? | Front Endocrinol (Lausanne) | 2024 | 38978628 | PubTator, text mining | PubMed |
| Developing drugs that promote remyelination: Is our in vitro screening approach too simplistic? | Neurotherapeutics | 2024 | 38937160 | PubTator, text mining | PubMed |
| Meta-Analytic Gene-Clustering Algorithm for Integrating Multi-Omics and Multi-Study Data. | Bioengineering (Basel) | 2024 | 38927823 | PubTator, text mining | PubMed |
| Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis. | Front Pharmacol | 2024 | 38887558 | PubTator, text mining | PubMed |
| N-butyl-β-carboline-3-carboxylate (β-CCB) systemic administration promotes remyelination in the cuprizone demyelinating model in mice. | Sci Rep | 2024 | 38886527 | PubTator, text mining | PubMed |
| Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer. | BMC Cancer | 2024 | 38872096 | PubTator, text mining | PubMed |
| Rapid and prolonged response of oligodendrocyte lineage cells in standard acute cuprizone demyelination model revealed by in situ hybridization. | Neurosci Lett | 2024 | 38852766 | PubTator, text mining | PubMed |
| Exploring the potential of Huangqin Tang in breast cancer treatment using network pharmacological analysis and experimental verification. | BMC Complement Med Ther | 2024 | 38849817 | PubTator, text mining | PubMed |
| A de novo designed coiled coil-based switch regulates the microtubule motor kinesin-1. | Nat Chem Biol | 2024 | 38849529 | PubTator, text mining | PubMed |
| nach0: multimodal natural and chemical languages foundation model. | Chem Sci | 2024 | 38846388 | PubTator, text mining | PubMed |
| Hydrophobic residues in S1 modulate enzymatic function and voltage sensing in voltage-sensing phosphatase. | J Gen Physiol | 2024 | 38771271 | PubTator, text mining | PubMed |
| The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas. | Front Immunol | 2024 | 38765008 | PubTator, text mining | PubMed |
| Influence of SLC40A1 on Cytokine Interactions and Immune Infiltration in Glioblastoma. | Neuromolecular Med | 2024 | 38750318 | PubTator, text mining | PubMed |
| Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer. | Aging (Albany NY) | 2024 | 38728242 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=8